bioRxivNeuroscience
A microRNA profile in Fmr1 knockout mice reveals microRNA expression alterations with possible roles in fragile X syndrome
Ting Liu, Rui-Ping Wan, Ling-Jia Tang, Shu-Jing Liu, Hai-Jun Li, Qi-Hua Zhao, Wei-Ping Liao, Xiao-Fang Sun, Yong-Hong Yi, Yue-Sheng Long
Abstract
Fragile X syndrome (FXS), a common form of inherited mental retardation, is caused by a loss of expression of the fragile X mental retardation protein (FMRP). FMRP is involved in brain functions by interacting with mRNAs and microRNAs (miRNAs) that selectively control gene expression at translational level. However, little is known about the role of FMRP in regulating miRNA expression. Here, we found a development-dependant dynamic expression of Fmr1 mRNA (encoding FMRP) in mouse hippocampus with a small peak at postnatal day 7 (P7). MiRNA microarray analysis showed that the levels of 38 miRNAs showed a significant increase with about 15~250 folds and the levels of 26 miRNAs showed a significant decrease with only about 2~4 folds in the hippocampus of P7 Fmr1 KO mice. Q-PCR assay showed that 9 of the most increased miRNAs (>100 folds in microarrays) were increased about 40~70 folds and their pre-miRNAs were increased about 5~10 folds, but no significant difference in their pri-miRNA levels was observed, suggesting a role of FMRP in regulating miRNA processing from pri-miRNA to pre-miRNA. We further demonstrated that a set of protein-coding mRNAs, potentially targeted by the 9 miRNAs were down-regulated in the hippocampus of Fmr1 KO mice. Finally, luciferase assays demonstrated that miR-34b, miR-340, miR-148a could down-regulate the reporter gene expression by interacting with the Met 3' UTR. Taken together these findings suggest that the miRNA expression alterations resulted from the absence of FMRP might contribute to molecular pathology of FXS.
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Drosophila FMRP recruits the miRISC to target mRNAs to repress translation
Navneeta Kaul, Sarala Joshi Pradhan, … Scott A. Barbee·bioRxiv·May 3, 2023
- Genetic removal of p70 S6K1 corrects coding sequence length-dependent alterations in mRNA translation in fragile X syndrome mice
Sameer Aryal, Francesco Longo, Eric Klann·Proceedings of the National Academy of SciencesPeer-reviewed·Apr 27, 2021
- Identification of FMRP target genes expressed in corticogenesis: implication for common phenotypes among neurodevelopmental disorders
Cristine R. Casingal, Takako Kikkawa, … Noriko Osumi·bioRxiv·Sep 18, 2019
- m⁶A-dependent FMRP control of DGKκ translation underlies core Fragile X phenotypes
Oktay Cakil, Boglárka Zámbó, … Hervé Moine·bioRxiv·Mar 10, 2026
- An iPSC model of fragile X syndrome reflects clinical phenotypes and reveals m6A-mediated epi-transcriptomic dysregulation underlying synaptic dysfunction
Lu Lu, Avijite Kumer Sarkar, … Ziyuan Guo·bioRxiv·Oct 14, 2024
- Transcriptional dysregulation and impaired neuronal activity in FMR1 knock-out and Fragile X patients iPSC-derived models.
Gilles Maussion, Cecilia Rocha, … Thomas M. Durcan·International Journal of Molecular SciencesPeer-reviewed·Oct 5, 2023